ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enalapril Maleate And Hydrochlorothiazide, and what generic alternatives are available?
Enalapril Maleate And Hydrochlorothiazide is a drug marketed by Chartwell Rx, Cosette, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Nostrum Labs Inc, Rising, and Taro Pharm Inds. and is included in seven NDAs.
The generic ingredient in ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Enalapril Maleate And Hydrochlorothiazide
A generic version of ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE was approved as enalapril maleate; hydrochlorothiazide by TARO PHARM INDS on September 18th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE?
Summary for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Patent Applications: | 9 |
DailyMed Link: | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE at DailyMed |
Pharmacology for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Physiological Effect | Decreased Blood Pressure Increased Diuresis |